<DOC>
	<DOCNO>NCT02314897</DOCNO>
	<brief_summary>Background Aims Pacemaker implantation treat bradyarrhythmias typically involve place pace lead tricuspid valve ( TV ) right ventricular ( RV ) apex . It known tricuspid regurgitation ( TR ) frequently result may lead increased morbidity mortality . Recently , leave ventricular ( LV ) pace epicardial vein via coronary sinus widely practice due advent biventricular pacing . This lead cross TV , potentially reduce risk TV dysfunction may also reduce risk LV dysfunction . The investigator hypothesize LV pace prevent onset new TR worsen pre-existing TR patient undergo pacemaker implantation . Methods Patients receive pacemaker sick sinus syndrome ( n=20 ) LV ejection fraction &lt; 40 % randomly allocate receive either conventional RV pace LV pace via coronary sinus . Serial 2D 3D transthoracic echocardiography perform implantation , one day post implantation , 1 week , 1 month , 6 month 1 year . The primary endpoint new onset TR diagnosis least moderate TR . Other endpoint include biventricular function , ventricular dyssynchrony , complication device implantation , mortality major cardiovascular event .</brief_summary>
	<brief_title>Left Ventricular Pacing Prevent Iatrogenic TR Pilot Study</brief_title>
	<detailed_description>We hypothesize left ventricular pace via coronary sinus approach reduce incidence significant tricuspid regurgitation pacemaker implantation patient normal leave ventricular function . The aim study compare degree tricuspid regurgitation cause pacemaker implantation conventional technique implant ventricular lead implant right ventricular apex versus implant ventricular lead leave ventricular epicardial vein via coronary sinus approach . The secondary objective study evaluate whether left ventricular pacing also less likely cause ventricular dyssynchrony dysfunction right ventricular apical pacing . This study single centre randomise clinical pilot study compare 2 different lead implantation technique assess use image technique follow clinical outcome . ( ) Proposed study interventions The procedure arm study identical except ventricular lead place . All part procedure , include implant equipment pace lead standard routine clinical practice . The left ventricular lead use study routinely use pacing leave ventricle patient receive biventricular pacemaker defibrillator heart failure . The implant site leave right prepectoral region venous access via either axillary subclavian vein approach . These choice leave implant physician 's discretion . Once venous access establish successfully patient randomly allocate either study arm . Patients randomize LV lead long coronary sinus sheath insert used perform occlusive venogram coronary sinus determine vein suitable leave ventricular lead placement . Those leave ventricular pace arm instead leave ventricular epicardial pace lead place apically possible large calibre leave ventricular branch coronary sinus . Patients right ventricular apical pacing arm endocardial active fixation pace lead place right ventricular apex conventional manner . Patients arm go right atrial active fixation lead place right atrial appendage . ( ii ) Methods protect source bias All patient refer Arrhythmia Service assess suitability take part study . Once recruit , study subject block randomise 1:1 fashion either conventional right ventricular lead implantation leave ventricular coronary sinus lead implantation . They blind allocation course study remove bias . Assessment echocardiograms perform 2 investigator blind patient 's treatment allocation . This pacemaker lead nearly always well visualised echocardiographic study make blind impossible . However , main outcome study quantitative measure TR biventricular function derive 3D echocardiography rather qualitative measure use previous study protect bias may cause echocardiogram assessor know allocation patient . The study also assess interobserver intraobserver variability look likelihood bias . ( iii ) Duration follow period Patients see post discharge 1 week wound care 1 month , 6 month 12 month pacemaker check pacemaker clinic . ( iv ) Frequency duration follow-up The scheduled follow follow . Note transthoracic echocardiography study include 2D 3D echocardiography 1 . Pre implant : transthoracic echocardiography 2 . Pacemaker implantation : randomisation venous access achieve . Blood sample take biomarker assay . 3 . Post implant day 1 : Pacemaker check , transthoracic echocardiography 4 . Post implant week 1 : Wound check , pacemaker check , transthoracic echocardiography 5 . Post implant month 1 : Wound check , pacemaker check , transthoracic echocardiography 6 . Post implant month 6 : Pacemaker check , transthoracic echocardiography , blood sample take biomarker assay . 7 . Post implant month 12 : Pacemaker check , transthoracic echocardiography</detailed_description>
	<mesh_term>Sick Sinus Syndrome</mesh_term>
	<mesh_term>Tricuspid Valve Insufficiency</mesh_term>
	<criteria>1 . Patients undergo dual chamber permanent pacemaker implantation sick sinus syndrome . This define symptomatic sinus node dysfunction manifest sinus pause excessive sinus bradycardia diagnose continuous ECG monitoring ambulatory ECG recording ( Holter study ) . 2 . Aged â‰¥21 year able give inform consent . The age limit patient able give inform consent personally . 1 . Left ventricular ejection fraction &lt; 40 % . 2 . Mobitz Type 2 second degree atrioventricular block , 2:1 atrioventricular block , high degree atrioventricular block complete heart block . 1 . Life expectancy less 1 year due medical comorbidities . 2 . Previous mechanical prosthetic tricuspid valve replacement , preclude implantation right ventricular apical lead . 3 . Tricuspid regurgitation least moderate severity . 4 . Complex congenital heart disease preclude placement either right ventricular apical lead leave ventricular lead via coronary sinus 5 . Vascular coronary sinus anatomy unfavourable either conventional RV lead leave ventricular lead implantation confirm coronary sinus venography time implantation . 6 . Pregnancy .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2014</verification_date>
</DOC>